Bulletin
Investor Alert

New York Markets Close in:

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

Market open

 --Real time quotes

Jul 7, 2022, 12:08 p.m.

/zigman2/quotes/203556943/composite

$

13.84

Change

-0.08 -0.57%

Volume

Volume 197,468

Real time quotes

/zigman2/quotes/203556943/composite

Previous close

$ 13.92

$ 13.84

Change

-0.08 -0.57%

Day low

Day high

$13.64

$14.12

Open

52 week low

52 week high

$6.51

$37.99

Open

Insider Actions for Deciphera Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/16/2022 Daniel L. Flynn
Chief Scientific Officer
1,768   Disposition at $10.75 per share. 19,006
06/16/2022 Matthew L. Sherman
EVP & Chief Medical Officer
1,768   Disposition at $10.75 per share. 19,006
06/16/2022 Daniel C. Martin
Chief Commercial Officer
1,311   Disposition at $10.75 per share. 14,093
06/16/2022 Thomas P. Kelly
Chief Financial Officer
1,768   Disposition at $10.75 per share. 19,006
06/16/2022 Jama Pitman
See Remarks
1,298   Disposition at $10.75 per share. 13,953
04/29/2022 Brightstar Associates LLC
1,478,978   Acquisition at $10 per share. 14,789,780
03/21/2022 Steven L. Hoerter
President and CEO; Director
3,150   Derivative/Non-derivative trans. at $9.11 per share. 28,696
02/16/2022 Daniel L. Flynn
Chief Scientific Officer
1,366   Disposition at $9.05 per share. 12,362
02/16/2022 Matthew L. Sherman
EVP & Chief Medical Officer
984   Disposition at $9.05 per share. 8,905
02/16/2022 Daniel C. Martin
Chief Commercial Officer
1,146   Disposition at $9.05 per share. 10,371
02/16/2022 Thomas P. Kelly
Chief Financial Officer
1,368   Disposition at $9.05 per share. 12,380
02/16/2022 Jama Pitman
See Remarks
1,146   Disposition at $9.05 per share. 10,371
01/18/2022 Daniel L. Flynn
Chief Scientific Officer
20,500   Award at $0 per share. 0
01/18/2022 Matthew L. Sherman
EVP & Chief Medical Officer
20,500   Award at $0 per share. 0
01/18/2022 Daniel C. Martin
Chief Commercial Officer
13,667   Award at $0 per share. 0
01/18/2022 Thomas P. Kelly
Chief Financial Officer
20,500   Award at $0 per share. 0
01/18/2022 Jama Pitman
See Remarks
13,667   Award at $0 per share. 0
12/15/2021 Daniel L. Flynn
Chief Scientific Officer
11,100   Award at $0 per share. 0
12/15/2021 Matthew L. Sherman
EVP & Chief Medical Officer
11,100   Award at $0 per share. 0
12/15/2021 Daniel C. Martin
Chief Commercial Officer
8,300   Award at $0 per share. 0
12/15/2021 Thomas P. Kelly
Chief Financial Officer
11,100   Award at $0 per share. 0
12/15/2021 Jama Pitman
See Remarks
8,300   Award at $0 per share. 0
10/04/2021 Matthew L. Sherman
EVP & Chief Medical Officer
2,659   Disposition at $33.17 per share. 88,199
05/03/2021 Michael D. Taylor
Director
300   Disposition at $46.75 per share. 14,025
05/03/2021 Michael D. Taylor
Director
7,700   Disposition at $46.07 per share. 354,739
05/03/2021 Michael D. Taylor
Director
5,646   Derivative/Non-derivative trans. at $3.95 per share. 22,301
05/03/2021 Michael D. Taylor
Director
2,354   Derivative/Non-derivative trans. at $1.89 per share. 4,449
04/20/2021 James A. Bristol
Director
1,700   Disposition at $45.6 per share. 77,520
04/20/2021 James A. Bristol
Director
1,700   Derivative/Non-derivative trans. at $3.95 per share. 6,715
04/19/2021 James A. Bristol
Director
1,300   Disposition at $46.66 per share. 60,658
04/19/2021 James A. Bristol
Director
4,000   Disposition at $46.13 per share. 184,520
04/19/2021 James A. Bristol
Director
5,300   Derivative/Non-derivative trans. at $3.95 per share. 20,935

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
5 Sales
1,478,978
7,913
Last 6 months
6 Purchases
11 Sales
1,567,812
17,073
Last 12 months
11 Purchases
12 Sales
1,617,712
19,732

Officers and Executives

Mr. Steven L. Hoerter
President & Chief Executive Officer
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Rodrigo Ruiz Soto
Senior Vice President-Clinical Development
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer & SVP
Ms. Kelley Dealhoy
Chief Business Officer & Senior Vice President
Mr. Daniel C. Martin
Chief Commercial Officer & SVP
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Chairman
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Link to MarketWatch's Slice.